Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.60, marking a -4% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.26%.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

While the confident stride through life with unexamined certainty, those who truly know themselves are caught in an endless ...

Forbes contributors publish independent expert analyses and insights. Sabrina Reed is a journalist who covers Hollywood and the TV industry. As is the case with Paradise, the season 2 finale tied up ...

Security researchers have discovered 10 new indirect prompt injection (IPI) payloads targeting AI agents with malicious ...

The interesting thing about The Dramais that the “twist” is not really a twist ending; it’s a twist beginning. Or… a twist a third of the way through. By the time the movie ends, it actually feels ...

Magic just didn’t do that. When The Walking Dead showed up as a mechanically unique Secret Lair in 2020, it sparked more ...

In just a few short months, Marathon has minted a highly quotable line: “Escape will make me God.” It’s also, according to ...

The current energy price shock is more likely to be disinflationary than inflationary once consumers absorb the initial impact, according to Will Hobbs, CIO of Brooks Macdonald. While markets face ...